Investing In Your Family's Health

Our Unique Process

From collection to shipping to processing to storage, we take care of your baby’s stem cells every step of the way.

Collection Kit

Before your baby is born, we'll send you a kit to bring to your healthcare provider when you deliver. The kit contains instructions for the collection of your sample.

Collection

Collecting your baby’s cord blood and tissue is safe and painless. Your doctor will use the kit to prepare your baby’s cord blood and tissue for processing and storage. Our kit contains the world's only collection device designed specifically for cord blood stem cells.

Transport

The collected blood and tissue is then shipped to our lab in a crush-resistant and temperature-protected container.

Processing

At the lab, we use AXP® Processing Technology to separate the stem cells from the cord blood. This process yields an average cell recovery rate of 99%, the highest in the industry. Your baby's cord tissue will be stored cryogenically.

Storage

Once processed, we safely store your baby’s cord blood stem cells and tissue in our cryogenic storage tanks for potential use in the future.

Quality Control

CBR’s lab is equipped with a temperature monitoring system that performs more than 2.5 billion quality checks per year and a sterility monitoring system that performs over 100,000 sample checks per year to help ensure the protection and quality of your family's sample.

Leading the Way

We've been unyielding in our focus on advancing cord blood stem cell product quality and science for the last 20 years.

Over that time, we've stored over 500,000 newborn stem cell units and have become the #1 recommended cord blood company by OB/GYNs* and expecting parents.

About Cord Blood Registry

Cord Blood Registry® (CBR®) is the world’s largest newborn stem cell company. Founded in 1992, CBR is entrusted by parents with storing samples from more than 500,000 children. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today.

Ultimate use of newborn stem cells will be determined by the treating physician who will consider if they are applicable for the condition and should come from the patient or a suitable donor (siblings of the same biological parents have a 25% chance of being a perfect match and a 50% chance of being a partial match; biological parents will always be a partial match). There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments (including regenerative medicine applications) will be available in the future.
For references, click here.